Edgar Filing: Verisk Analytics, Inc.

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â McConnell Glenn A.

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2017

3. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [VRSK]

(Last)

(First)

(Middle)

C/O VERISK ANALYTICS, INC,Â 545 WASHINGTON BOULEVARD

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Principal Accounting Officer

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

JERSEY CITY,Â NJÂ 07310

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	27,481 ⁽¹⁾	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option ⁽²⁾	Â ⁽³⁾	03/01/2018	Common Stock	30,000	$ 17.24	D	Â
Stock Option ⁽²⁾	Â ⁽³⁾	04/01/2019	Common Stock	35,000	$ 16.1	D	Â
Stock Option ⁽⁴⁾	Â ⁽³⁾	10/06/2019	Common Stock	25,000	$ 22	D	Â
Stock Option ⁽⁴⁾	Â ⁽³⁾	04/01/2020	Common Stock	16,500	$ 28.2	D	Â
Stock Option ⁽⁴⁾	Â ⁽³⁾	04/01/2021	Common Stock	11,092	$ 33.3	D	Â
Stock Option ⁽⁴⁾	Â ⁽³⁾	04/01/2022	Common Stock	6,387	$ 46.97	D	Â
Stock Option ⁽⁴⁾	Â ⁽⁵⁾	04/01/2023	Common Stock	6,775	$ 61.14	D	Â
Stock Option ⁽⁶⁾	Â ⁽⁷⁾	04/01/2024	Common Stock	10,524	$ 59.74	D	Â
Stock Option ⁽⁶⁾	Â ⁽⁸⁾	04/01/2025	Common Stock	9,717	$ 71.53	D	Â
Stock Option ⁽⁶⁾	Â ⁽⁹⁾	04/01/2026	Common Stock	8,798	$ 80.19	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
McConnell Glenn A. C/O VERISK ANALYTICS, INC 545 WASHINGTON BOULEVARD JERSEY CITY,Â NJÂ 07310	Â	Â	Â Principal Accounting Officer	Â

Signatures

/s/ Kenneth E. Thompson, Attorney-in-Fact		01/11/2017
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This amount includes 4,481 restricted shares of Common Stock that were granted under the Issuer's 2009 Equity Incentive Plan and 2013 Equity Incentive Plan. Subject to the terms of the Issuer's 2009 Equity Incentive Plan and 2013 Equity Incentive Plan and the applicable award agreements thereunder, these restricted shares vest in four equal installments on the first, second, third and fourth anniversaries of their respective grant dates.
(2)	Stock Options outstanding under the Issuer's 1996 Incentive Plan.
(3)	Immediately.
(4)	Stock Options outstanding under the Issuer's 2009 Equity Incentive Plan.
(5)	5,081 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 1,694 shares will become exercisable on 4/1/2017.
(6)	Stock Options outstanding under the Issuer's 2013 Equity Incentive Plan.
(7)	5,262 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 5,262 shares will become exercisable as follows: 2,631 shares on 4/1/2017, and 2,631 shares on 4/1/2018.
(8)	2,429 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 7,288 shares will become exercisable as follows: 2,429 shares on 4/1/2017, 2,429 shares on 4/1/2018 and 2,430 shares on 4/1/2019.
(9)	The 8,798 shares of Common Stock underlying this Stock Option will become exercisable as follows: 2,199 shares on 4/1/2017, 2,199 shares on 4/1/2018, 2,200 shares on 4/1/2019, and 2,200 shares of 4/1/2020.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.